This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

17 Aug 2020

Sai Life Sciences opens new Research & Technology Centre in Hyderabad

Inauguration of Sai Life Sciences’ new Research & Technology Centre. Seen in the picture from left to right – Krishna Kanumuri, CEO & MD Sai Life Sciences, Sri K T Rama Rao, Hon'ble Minister for IT, Industries, MA & UD and Jayesh Ranjan, Principal Secretary to Government Industries and Commerce. (PRNewsfoto/Sai Life Sciences)

One of India's fastest growing CDMOs goes "beyond the norm" to reinvent itself as a new generation global CDMO.

Sai Life Sciences has inaugurated its new Research and Technology (R&T) Centre in Hyderabad, India.

The company claims the new R&T facility has several unique aspects such as intelligent and ergonomic lab design to enhance safety and productivity, advanced automation for seamless data capture during process development, lean & 5S approach to enhance productivity and collaborative workspaces for engendering innovation.

Krishna Kanumuri, CEO & Managing Director of Sai Life Sciences said the company's philosophy behind building this new facility was to "go beyond what the norm is in India and to create what our global innovator partners expect in their inhouse capabilities".

The new 83,000-sq. ft (7700 m2) facility houses state-of-the-art research capabilities and advanced technology platforms, augmenting the company's capabilities in providing superior scientific solutions to its pharma and biotech innovator customers globally. It has 24 chemistry labs with 250 fume hoods, analytical labs, fully equipped technology suite and a dedicated process safety lab.

Sai Life Sciences began a process of organizational transformation in 2019 reinventing itself as a new generation global CDMO. Through this initiative, named Sai Nxt, the company is investing more than $150 million (> INR 1000 Cr) to expand and upgrade its R&D and manufacturing facilities, induct top global scientific and leadership talent, strengthen automation and data systems, and raise the bar for safety, quality and customer focus.

Related News